INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Clinical trials for INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER) explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER) trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New inhaled therapy aims to slow lung scarring in progressive fibrosis
Disease control Recruiting nowThis study tests an inhaled version of the drug pirfenidone (AP01) in 375 adults with progressive pulmonary fibrosis (PPF), a condition where lung scarring worsens over time. Participants receive either a high dose, low dose, or placebo twice daily for 52 weeks, alongside their u…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated May 26, 2026 06:15 UTC
-
New combo aims to shield scarred lungs during cancer radiation
Disease control Recruiting nowThis study tests whether adding the drug BIO 300 to standard chest radiation can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease (lung scarring). About 25 participants will receive both t…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New study aims to cut diagnostic delays for lung disease patients
Knowledge-focused Recruiting nowThis study tests whether bundling key tests (like CT scans and lung function tests) into a single, coordinated appointment can speed up diagnosis for people with suspected interstitial lung disease. Researchers will compare this streamlined approach to the usual, often fragmented…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: NA • Sponsor: Hospital de Granollers • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Streamlined lung care: one visit to rule them all?
Knowledge-focused Recruiting nowThis study tests a new way to manage follow-up care for people with interstitial lung disease (ILD). Instead of making multiple trips for tests and doctor visits, patients in the optimized group get everything done in one coordinated hospital visit. The goal is to see if this red…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: NA • Sponsor: Hospital de Granollers • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC